Changes in plasma B-type natriuretic peptide after allograft renal transplantation

Nephrology

Volumn 12, Issue 1, 2007, Pages 102-106

  Wei, Tie Min ^a   Jin, Lie ^a   Lv, Ling Chun ^a   Zhang, Bao Jin ^a   Wang, Le Xin ^b  

^a LISHUI CENTRAL HOSPITAL   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

BNP; Kidney; Renal transplantation

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DYNAMICS; FEMALE; GRAFT DYSFUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 33846991614     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00741.x     Document Type: Article

References (16)

1. Nakamura S, Naruse M, Naruse K et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am. J. Hypertens. 1991; 4: 909-12.
2. Tsutamoto T, Wada A. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.
3. Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002; 347: 161-7.
4. Wei TM, Zeng CL, Chen LP et al. Bedside test of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in patients with hypertension. Eur. J. Heart. Fail. 2005; 7: 75-9.
5. de Lemos JA, Marrow DA, Bentley JH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 2001; 345: 1014-21.
6. Morrow DA, de Lemos JA, Sabatine MS et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST - elevation myocardial infarction. J. Am. Coll. Cardiol. 2003; 41: 1264-72.
7. Sun TW, Wang LX, Zhang YZ. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. Arch. Med. Res. 2006; 37: 502-5.
8. Vickery S, Price CP, John RI et al. B-type Natriuretic Peptide (BNP) and amino-terminal proBNP in patients with CKD: Relationship to renal function and left ventricular hypertrophy. Am. J. Kidney Dis. 2005; 46: 610-20.
9. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J. Invest. Med. 2005; 53: 366-70.
10. Bertinchant JP. Brain natriuretic peptide (BNP) and N-terminal-proBNP in chronic haemodialysed renal failure. Arch. Mal. Coeur. Vaiss. 2004; 97: 881-8.
11. Zeng CL, Wei TM, Jin L, Wang LX. The value of plasma B-type natriuretic peptide in patient of chronic renal dysfunction with dialysis. Intern. Med. J. 2006; 36: 552-7.
12. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N. Engl. J. Med. 1998; 339: 321-8.
13. Kone BC. Molecular biology of natriuretic peptides and nitricoxide synthases. Cardiovasc. Res. 2001; 51: 429-41.
14. Cataliotti A, Malatino L, Jougasaki M et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo. Clin. Proc. 2001; 76: 1111-19.
15. Clerico A, Capriolo R, Del Ry S, Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J. Endocrinol. Invest. 2001; 24: 24-30.
16. Rush DN, Nickson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J. Am. Soc. Nephrol. 1998; 9: 2129-34.